Call for Abstract
7th World Hematologists Congress , will be organized around the theme “A Step Towards Excellence in Hematology Research ”
Hematologists 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Hematologists 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Hematology also spelled as Haematology, is the branch of medicine that came into picture with the study, diagnosis, treatment of diseases associated with the blood and blood components. Hematology involves the study of etiology (Origin of disorder). It includes blood diseases treatment that have an significant effect on the assembly of blood and its components, like blood cells, bone marrow, blood proteins, hemoglobin, blood vessels, platelets, spleen, and also the mechanism of clotting. Physicians specialized in hematology are known as Hematologists or Haematologists. Their conventional work mainly includes the care and treatment of patients with haematological diseases. Hematologists moreover conduct studies in oncology and work with oncologists, specialized in this field are known as Hemato-oncologists and their work is to deal with Cancers related to blood. There are varied hematologic disorders that can affect people. Some of those are bleeding disorders, anemia, hemophilia, general blood clots, etc. As for connected blood cancers such as lymphoma leukemia, and myeloma are also a serious threat. As this a successive conference of Hematology conference series, join to have a glimpse of hematology and hematology research at this conference.
- Track 1-1Blood Components
- Track 1-2Platelets & Thrombocytopenia
- Track 1-3Hemoglobin & Blood Plasma
- Track 1-4Erythrocytes & Leukocytes
- Track 1-5Complete Blood Count & Polycythemia
- Track 1-6Reticuloendothelial & Lymphatic System
If anyone is having blood disorder, it can disturb your total health. Because blood is the main fluid of our body. There are many different blood conditions that can affect people such as blood cancers, thrombosis, Anemia, haemophilia, Thalassemia and many more. Mainly blood disorders include, platelets disorders, (White Blood Cell) WBCs disorders, red blood cells (RBCs) disorders such as Anemia, which is the most common among all other blood disorder, according to fact more than three million Americans are affected by Anemia. Sickle cell anemia and Thalassemia are the genetic forms of anaemia. The most common inherited bleeding disorders are Hemophillia and the Von Willebrand disease. Blood disorders furthermore include blood platelets disorders such as: Thrombocytopenia, A condition in which platelets counts of blood decreases, causing a low platelets number in the blood. Thrombosis i.e. formation of a blood clots in blood vessels, which restrict the blood flow through circulatory system. There are much more blood diseases that are going to be discussed in Hematologists 2017
- Track 2-1Red Blood Cell Disorders
- Track 2-2White Blood Cell Disorders
- Track 2-3Platelet Disorders
- Track 2-4Blood Plasma Disorders
- Track 2-5Hemorrhagic Disorders
- Track 2-6Hemoglobinopathy
- Track 2-7Lymphocytic, Monocyte & Granulocyte Disorders
- Track 2-8Different Types of Anemia
- Track 2-9Genetic Blood Disorders
- Track 2-10Coagulopathies
- Track 2-11Thalassemias
- Track 2-12Blood Infections
- Track 2-13Other Blood Disorders
Blood cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. So it needs to be cover in discussion of Blood Disorders Conferences. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. A major part of blood based research is going on in this field. Leukaemia mainly affects the white blood cells (WBCs) and are closely linked to the lymphomas and some of them are deeply related to the adult T cells leukaemia, these disorders comes under the lymph proliferative disorders. The cancer which originates from WBCs (white blood cells) is known as lymphoma and this type of disorder is mainly seen in Hodgkin lymphoma these diseases can be treated with hematopoietic stem cell transplantation, radiation therapy and chemotherapy. The bone marrow in which a large number of white blood cells develop that leads to multiple myeloma.
- Track 3-1Leukaemia
- Track 3-2Lymphoma
- Track 3-3Myeloma
- Track 3-4Myelodysplastic syndromes
- Track 3-5Multiple Myeloma
- Track 3-6Non-Hodgkin Lymphoma
- Track 4-1Blood and Marrow Related Disorders
- Track 4-2Lymph Associated Disorders
- Track 4-3Infection Related Disorders
- Track 4-4Immunodeficiency Disorders
- Track 4-5Reticuloendothelial System Disorders
Immunohematology is known as blood banking as well, is a branch of Hematology which studies antigen-antibody reactions and similar phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. People working in this field are noted to as an immuno-hematologist. Their usual duties include cross-matching, blood typing and antibody identification. This area is dealing with preparing blood, blood components etc. for transfusion and assortment of more compatible components for blood transfusion. People might be immunized to RBCs due to prior exposure to RBCs of other persons, mostly through pregnancy or transfusion. Red blood cells have antigens on them. If a woman is pregnant with a foetus or an individual is transfused with blood that holds antigen which does not match with recipient or mother, this may cause formation of antibodies against blood antigen in the individual. These antibodies may then destroy RBCs which possess the antigen if further transfusions are required. This is why all blood banks go for screening of potential blood recipients for unexpected antibodies and they then select only that blood which lacks offending antigen. The formation of these antibodies is a rare occurrence, approximately 0.1-3% of the general population
- Track 5-1Immunology
- Track 5-2Blood Group Systems
- Track 5-3Blood Transfusion
- Track 5-4Pretransfusion Testing
- Track 5-5Rh Sensitization
- Track 5-6Artificial Blood
- Track 5-7Hazards of Transfusion
- Track 5-8Immunotyping
Oncology and Hematology is the diagnosis and treatment of all type of malignancies (cancers) that occur in adults. Treatment includes chemotherapy, radiotherapy, immunotherapy and pathway directed agents etc. Bone marrow transplantation or peripheral stem cell transplantation is also advanced used therapies now days. The Oncology's physicians specialize in all types of cancers including: lymphomas, leukaemia, multiple myeloma, breast, melanoma, lung, gastrointestinal, urologic, brain cancer, and all other types of cancer. Specialists, who are experts in the treatment of patients with blood diseases such as anaemia, bleeding disorders, and clotting problems, are known as Hemato-oncologists. Based on their specialization Hemato-oncologists are subcategorising as the Paediatric Hem/Oncologists, the adult Hem/Oncologists.
- Track 6-1Advances in Hematology and Oncology
- Track 6-2Organ Specific Oncology
- Track 6-3Oncogenomics
- Track 6-4Cancer Diagnosis and Therapy
After the physical examination, for the detection of blood disorders Physician usually go for Complete blood count (CBC). This is the basic test after that to diagnose a person's blood disorder, the doctor usually must do further blood tests Once a doctor/consultant finds that something is wrong with one or more of the blood cell types, many additional tests are available for further detection of disease. Doctors can measure proportion of the different types of WBCs (white blood cells) and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Tests are performed to measure the ability of white blood cells to fight foreign body/ infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anaemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow sample as well for Bone Marrow Examination. Once the problem is diagnosed Hematologists go for the appropriate treatment for particular problem. Now a days we have several methods to treat blood cancers such as Chemotherapy, Radiation therapy etc. Now a days advanced technique such as gene therapy is being used to treat Blood disorders. Researchers are attempting to search out ways that to correct the defective genes that cause Blood Disorders. Gene therapy hasn't nonetheless developed to the purpose that it's accepted treatment for Blood Disorder. However, researchers still take a look at gene therapy in clinical trials. Bone Marrow Transplantation, Hematopoietic stem cell therapy and Cord blood transplantation are new rising varieties of treatment for blood disorders.
- Track 7-1Complete Blood Count (CBC)
- Track 7-2Screening Tests
- Track 7-3Bone Marrow Examination and Biopsy
- Track 7-4Prenatal Diagnosis
- Track 7-5Bone Marrow Transplantation
- Track 7-6Gene Therapy
- Track 7-7Cord Blood Transplantation
- Track 7-8Stem Cell Therapy
- Track 7-9Therapeutic Drugs
- Track 7-10Coagulation & Anticoagulation Therapies
- Track 7-11Surgeries & Other Invasive Therapies
- Track 8-1Laboratory Hematology
- Track 8-2Hematology Testing
- Track 8-3Hematology Research
- Track 8-4Animals Model in Hematology
- Track 8-5Clinical trials
Hematopathology or hemopathology is the subdivision of pathology which studies disorders of hematopoietic cells. Hematopathology is a certified subspecialty, practiced by those physicians who have finished general pathology residency (clinical, anatomic or combined). The Hematopathology department delivers diagnostic services & specialized testing for patients with all types of hematologic disorders. The Hematopathology laboratory offers diagnostic evaluation of blood, lymph nodes, bone marrow, spleen and hematolymphoid lesions in other sites and consist of faculty and staff with expertise in both clinical and anatomic pathology.
- Track 9-1Pathology
- Track 9-2Molecular Hematopathology
- Track 9-3Hematopathology Morphology
- Track 9-4Metabolic Hematology
- Track 9-5Cell Kinetics
- Track 9-6Clinical Biochemical Genetics
- Track 9-7Molecular Genetic Pathology
Pediatric Hematology is a branch of Hematology which deals with the treatment and care of child or teen having Blood Disorder. A paediatric hematologist has the qualifications and experience to evaluate and treat child or teen with Hematologic Disorders. The caring nature to deal with children or teens with blood diseases and blood cancers is learned from progressive training and experience in practice. Pediatric hematologists treat children and teens from birth through young adulthood. Children and teens with blood disorders need special attention than adults. Their bodies are growing and have distinctive medical needs. They normally express their concerns in a different way than adults do. They are not always able to be easy-going and cooperative. Pediatric hematologists know how to examine and treat them in a way to makes them relaxed and cooperative. Even most pediatric hematologists offices are arranged and decorated according to children and teens in mind.
Blood tests are done on animals for a variety of reasons. Screening tests, such as a complete blood count (CBC), may be done on clinically normal animals when they are acquired to avoid a financial and/or emotional commitment to a diseased animal, to examine geriatric patients for subclinical disease, or to identify a condition that might make an animal an anesthetic or surgical risk. Screening tests are often done when an ill animal is first examined, especially if systemic signs of illness are present and a specific diagnosis is not apparent from the history and physical examination. Tests may be done to assist in the determination of the severity of a disease, to help formulate a prognosis, and to monitor the response to therapy or progression of disease. Decisions to request hematology tests in animals are largely based on the cost of the test versus the potential benefit of the result to the animal. A CBC is routinely done to establish a database for patient evaluation, while other hematology tests may be done in an attempt to evaluate a specific problem.
- Track 11-1Veterinary Hematologists
- Track 11-2Diagnosis & Treatment
- Track 11-3Animal Testing
- Track 11-4Animal Genomics
Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. They may also assist with blood transfusions, blood tests, research, and chemotherapy. If you go into hematology, expect to have more responsibility than other nurses, prescriptive authority, and the ability to order diagnostic lab work. Some of the more commonly-known blood diseases and disorders a hematology nurse may encounter include: leukemia, lymphoma, sickle cell anaemia and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children i.e. Pediatric Hematology nurses. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research and chemotherapy. Advanced practice hematology nursing have some prescriptive authority and can also order diagnostic lab work done.
- Track 12-1Hematology Nursing Practice
- Track 12-2Pediatric Hematology Nursing
- Track 12-3Surgical Hematology Nursing
- Track 12-4Blood Cancer Pain Management
- Track 12-5Veterinary Hematology Nursing
- Track 13-1Hematology and Pharma industry
- Track 13-2Hematology Pharmacology
- Track 13-3Hematology and Drugs
- Track 13-4Noval Discoveries in Hematology Pharma Market
Stem cells have the remarkable potential to turn into many different cell types within the body throughout formative years and growth. Additionally, in several tissues they function as a sort of internal repair system, dividing basically without any limit to replenish other cells as long as the person or animal continues to be alive. Once a stem cell divides, each newly developed cell has the potential to stay as a stem cell or become another variety of cell with a more specialised function, like a muscle cell, a red blood corpuscle, or a nerve cell. Stem-cell therapy is the use of stem cells to treat or cure a disease or condition. Bone marrow transplant is the most commonly used stem-cell therapy, however some therapies derived from umbilical cord blood also are in use. A stem cell transplant is a treatment for many forms of cancer. For instance, you might have one if you have leukaemia, myeloma, or some types of lymphoma. Doctors conjointly treat some blood diseases with stem cell transplants.
- Track 14-1Stem Cell Therapy
- Track 14-2Different Types of Stem Cell
- Track 14-3Tissue Regeneration
- Track 14-4Stem Cell Biomarkers
- Track 14-5Stem Cell Products
The global Hematology diagnostics and drugs market is likely to expand from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a five-year compound annual growth rate (CAGR) of 7.5%. A Blood disorder, the chief segment is anticipated to reach nearly $57.3 billion and $80 billion in 2015 and 2020, respectively, representing five-year CAGR of 6.9%. Hematological oncology is the fastest-growing segment, should raise almost $24 billion in 2015 to $38.2 billion in 2020 at a five-year CAGR of 9.7%. Reagents and diagnostics as a segment should reach $6.1 billion in 2020 at a five-year CAGR of 3.2%.
The Americas controlled the largest share of 41.75% of the worldwide Hematology market at a predicted $1,810.4 million in 2013, anticipated to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second largest Hematology market share. Germany controlled the largest share almost 20% of the European market at an expected $272.8 million in 2013, and is estimated to grasp $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asia and Middle East Hematology market is growing in double digits and will remain to grow in the upcoming years. China controlled the largest share of almost 53% of the Asian Hematology market at an expected $216.0 million in 2013, estimated and is to grasp $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.
- Track 16-1Hematology Pharma Market
- Track 16-2Hematology Reagents Market
- Track 16-3Hematology Equipments Market
- Track 16-4Hematology Diagnostics Market
Hematology researchers are making significant discoveries in varied fields, extending from the most central cellular investigations, to the most chief edge translational and clinical Hematology research. Advances in the field of Hematology are leading towards novel treatments for Hematologic disorders every day, giving patients a hope that greater discoveries lie ahead. Through clinical trials diagnosing canters become more accurate, Radiation and surgical techniques have advanced, medications are more effective, Combinations of medical, surgical and radiation therapy are increasing treatment effectiveness and enhancing outcomes. Strategies to address the late effects of cancer and Hematology and its treatment are improving quality of life.
A case report is usually considered a kind of anecdotal proof. Given their intrinsic method limitations, including absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases, moreover as uncommon presentations of common diseases. They can facilitate generate study hypotheses, as well as plausible mechanisms of disease. Case reports might also have a task to play in guiding the personalization of treatments in clinical follow. Therefore it's important to incorporate case reports in Hematologists conferences